SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis

Medulloblastoma (MB) is the most common malignant brain tumor in childhood. It contains at least four distinct molecular subgroups. The aim of this study is to explore novel diagnostic and potential therapeutic markers within each subgroup of MB, in particular within Group 4, the largest subgroup, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yong‐Xiao, Yu, Zhen‐Wei, Jiang, Tao, Shao, Li‐Wei, Liu, Yan, Li, Na, Wu, Yu‐Feng, Zheng, Chen, Wu, Xiao‐Yu, Zhang, Ming, Zheng, Dan‐Feng, Qi, Xue‐Ling, Ding, Min, Zhang, Jing, Chang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891175/
https://www.ncbi.nlm.nih.gov/pubmed/29369502
http://dx.doi.org/10.1111/cas.13515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891175/
https://www.ncbi.nlm.nih.gov/pubmed/29369502
http://dx.doi.org/10.1111/cas.13515

Ejemplares similares